Tags

Type your tag names separated by a space and hit enter

Complementary medicine use in children and young adults with inflammatory bowel disease.
Am J Gastroenterol. 2002 Feb; 97(2):382-8.AJ

Abstract

OBJECTIVES

We examined the use of complementary alternative medicine (CAM) in children and young adults with inflammatory bowel disease.

METHODS

After validation of a questionnaire and completion of a pilot survey, children and young adults with inflammatory bowel disease were enrolled in three centers of pediatric gastroenterology (Boston, Detroit, and London).

RESULTS

Two hundred eight questionnaires were completed in total (Boston, 120; Detroit, 37; London, 51). Ages ranged from 3.8 to 23.0 yr, 58% were male, 57% had Crohn's disease, and 35% had ulcerative colitis. The frequency of CAM use was 41%. The most common CAMs were megavitamin therapy (19%), dietary supplements (17%), and herbal medicine (14%). Parental CAM use and the number of adverse effects from conventional medicines were predictors of CAM use (odds ratio = 1.9, 95% CI = 1.2-3.1, p = 0.02; odds ratio = 1.3, 95% CI = 1.2-1.5, p < 0.001, respectively). The most important reasons respondents gave for using CAM were side effects from prescribed medicines, prescribed medicines not working as well as they had hoped, and hoping for a cure. Fifty-nine percent of respondents not taking CAM were interested in learning more about it.

CONCLUSIONS

In our survey over 40% of children with chronic inflammatory bowel disease used complementary medicine in addition to conventional therapies. Parental CAM use and number of adverse effects from conventional therapies were the only independent predictors of CAM use. Some complementary therapies have potential for adverse effects and for drug interactions with conventional treatments. Physicians should take a thorough history of CAM use in children with chronic inflammatory bowel disease.

Authors+Show Affiliations

Center for Pediatric Gastroenterology, Royal Free Hospital, London, United Kingdom.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

11866277

Citation

Heuschkel, Robert, et al. "Complementary Medicine Use in Children and Young Adults With Inflammatory Bowel Disease." The American Journal of Gastroenterology, vol. 97, no. 2, 2002, pp. 382-8.
Heuschkel R, Afzal N, Wuerth A, et al. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol. 2002;97(2):382-8.
Heuschkel, R., Afzal, N., Wuerth, A., Zurakowski, D., Leichtner, A., Kemper, K., Tolia, V., & Bousvaros, A. (2002). Complementary medicine use in children and young adults with inflammatory bowel disease. The American Journal of Gastroenterology, 97(2), 382-8.
Heuschkel R, et al. Complementary Medicine Use in Children and Young Adults With Inflammatory Bowel Disease. Am J Gastroenterol. 2002;97(2):382-8. PubMed PMID: 11866277.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Complementary medicine use in children and young adults with inflammatory bowel disease. AU - Heuschkel,Robert, AU - Afzal,Nadeem, AU - Wuerth,Anne, AU - Zurakowski,David, AU - Leichtner,Alan, AU - Kemper,Kathi, AU - Tolia,Vasundhara, AU - Bousvaros,Athos, PY - 2002/2/28/pubmed PY - 2002/3/15/medline PY - 2002/2/28/entrez SP - 382 EP - 8 JF - The American journal of gastroenterology JO - Am J Gastroenterol VL - 97 IS - 2 N2 - OBJECTIVES: We examined the use of complementary alternative medicine (CAM) in children and young adults with inflammatory bowel disease. METHODS: After validation of a questionnaire and completion of a pilot survey, children and young adults with inflammatory bowel disease were enrolled in three centers of pediatric gastroenterology (Boston, Detroit, and London). RESULTS: Two hundred eight questionnaires were completed in total (Boston, 120; Detroit, 37; London, 51). Ages ranged from 3.8 to 23.0 yr, 58% were male, 57% had Crohn's disease, and 35% had ulcerative colitis. The frequency of CAM use was 41%. The most common CAMs were megavitamin therapy (19%), dietary supplements (17%), and herbal medicine (14%). Parental CAM use and the number of adverse effects from conventional medicines were predictors of CAM use (odds ratio = 1.9, 95% CI = 1.2-3.1, p = 0.02; odds ratio = 1.3, 95% CI = 1.2-1.5, p < 0.001, respectively). The most important reasons respondents gave for using CAM were side effects from prescribed medicines, prescribed medicines not working as well as they had hoped, and hoping for a cure. Fifty-nine percent of respondents not taking CAM were interested in learning more about it. CONCLUSIONS: In our survey over 40% of children with chronic inflammatory bowel disease used complementary medicine in addition to conventional therapies. Parental CAM use and number of adverse effects from conventional therapies were the only independent predictors of CAM use. Some complementary therapies have potential for adverse effects and for drug interactions with conventional treatments. Physicians should take a thorough history of CAM use in children with chronic inflammatory bowel disease. SN - 0002-9270 UR - https://www.unboundmedicine.com/medline/citation/11866277/Complementary_medicine_use_in_children_and_young_adults_with_inflammatory_bowel_disease_ L2 - https://Insights.ovid.com/pubmed?pmid=11866277 DB - PRIME DP - Unbound Medicine ER -